Cftr was ranked in the top 10% to 50% of CIS CRC cancer-driver genes in screens in adenomatous polyposis coli (Apc) wild-type [39], Apc-deficient [40], and transforming growth factor-beta (TGF beta)-deficient [41] genetic backgrounds. Here, APC is linked to in situ carcinoma.